About the Journal

IIAR Journal of Pharmaceutical Sciences (IIAR-JPS) is a scholarly, peer-reviewed, open-access journal published by the International Institute of Artificial Intelligence and Research (IIAR). The journal provides a platform for researchers, academics, healthcare professionals, and industry practitioners to disseminate high-quality research and contribute to the advancement of pharmaceutical sciences.

Focus and Scope

IIAR-JPS welcomes original research articles, review articles, systematic reviews, case studies, short communications, and other scholarly contributions covering areas including:

  • Pharmaceutical Chemistry

  • Pharmaceutics

  • Pharmacology

  • Pharmacognosy

  • Medicinal Chemistry

  • Drug Discovery and Development

  • Pharmaceutical Biotechnology

  • Clinical Pharmacy

  • Pharmacotherapy

  • Toxicology

  • Pharmaceutical Analysis

  • Drug Delivery Systems

  • Clinical and Translational Pharmaceutical Research

  • Pharmaceutical Technology

  • Emerging Innovations in Pharmaceutical Sciences

The journal encourages interdisciplinary research and studies addressing contemporary challenges in pharmaceutical sciences, healthcare, drug development, and related fields.

Open Access Policy

IIAR-JPS is committed to providing immediate and unrestricted open access to its published research. Readers may access, read, download, and use published articles in accordance with the journal's stated licensing terms.

The journal supports open dissemination of scientific knowledge while maintaining rigorous standards of peer review, research integrity, and publication ethics.

Peer Review

All research manuscripts submitted to IIAR-JPS undergo editorial assessment and peer review before publication. The journal is committed to maintaining a fair, transparent, and rigorous review process.

Copyright and Licensing

Authors retain copyright of their published work, subject to the publication agreement and licensing terms adopted by the journal. The applicable Creative Commons license will be clearly stated on each published article.

Authors are responsible for ensuring that their submissions are original and that all necessary permissions and acknowledgements are obtained for third-party materials.

Publication Ethics

IIAR-JPS is committed to maintaining high standards of academic and publication integrity. The journal does not tolerate plagiarism, fabrication or falsification of data, duplicate publication, inappropriate authorship, citation manipulation, or other forms of research misconduct.

Authors, reviewers, and editors are expected to uphold principles of academic integrity, transparency, confidentiality, and responsible scholarly communication.

Sponsorship and Funding Disclosure

IIAR-JPS is published by the International Institute of Artificial Intelligence and Research (IIAR). Any financial support, sponsorship, institutional relationship, or potential conflict of interest relevant to a particular publication will be disclosed where applicable.

Journal History

IIAR Journal of Pharmaceutical Sciences was established in 2026 by the International Institute of Artificial Intelligence and Research (IIAR) to support the dissemination of high-quality pharmaceutical research and strengthen scholarly communication within pharmaceutical sciences and related disciplines.

Archiving

The journal is committed to the long-term preservation and accessibility of its published scholarly content. Digital preservation arrangements, including participation in recognized archival systems such as LOCKSS or CLOCKSS, will be implemented as the journal develops its digital preservation infrastructure.

Privacy Statement

Names, email addresses, affiliations, and other personal information entered into the journal's OJS platform will be used solely for the stated purposes of the journal, including manuscript submission, peer review, editorial communication, publication, and related scholarly activities.

The journal will not make personal information available for unrelated purposes or sell or distribute such information to third parties without appropriate authorization.